Correlation Between Pliant Therapeutics and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Pliant Therapeutics and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Madrigal Pharmaceuticals.
Diversification Opportunities for Pliant Therapeutics and Madrigal Pharmaceuticals
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Pliant and Madrigal is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Madrigal Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pliant Therapeutics is 1.15 times less risky than Madrigal Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Madrigal Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 23,620 in Madrigal Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 11,125 from holding Madrigal Pharmaceuticals or generate 47.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Pliant Therapeutics |
| Madrigal Pharmaceuticals |
Pliant Therapeutics and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Madrigal Pharmaceuticals
The main advantage of trading using opposite Pliant Therapeutics and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Pliant Therapeutics vs. Eliem Therapeutics | Pliant Therapeutics vs. HCW Biologics | Pliant Therapeutics vs. Scpharmaceuticals | Pliant Therapeutics vs. Milestone Pharmaceuticals |
| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. HCW Biologics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |